Role of certain blood tests(serum TWEAK and hematologic markers) in predicting the severity of acute pancreatitis

Not Applicable

• Conditions: Health Condition 1: K85- Acute pancreatitis

• Registration Number: CTRI/2020/01/022591
• Lead Sponsor: JIPMER intrumural fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

All patients over the age of 18 with acute pancreatitis

presenting within 72 hours of onset of symptoms, admitted to the surgery

emergency will be included in the study.

Exclusion Criteria

patients on antiplatelet therapy, autoimmune diseases,

hematologic diseases, HIV positive and patients on immunosuppression

will be excluded from the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
THE PRIMARY OUTCOME VARIABLES ARE values of serum TWEAK, Immature granulocyte <br/ ><br>percentage, Neutrophil to lymphocyte ratio and mean platelet volume.Timepoint: the time points include blood investigations at admission and 24 hours after admission

Secondary Outcome Measures

Name	Time	Method
THE SECONDARY OUTCOME VARIABLE IS THE VALUES OF SERUM PROALCITONINTimepoint: NO APPLICABLE